AGMB
AgomAb Therapeutics N.V. American Depositary Shares
There isn't enough reported data to score AGMB yet.
AGMB Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate AGMB's fundamentals.
AGMB PE Valuation
AGMB has no meaningful PE right now: it lost money over the past year.
AGMB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| -- | |
| -- | |
| Limited | |
| High |
Analysts expect AGMB's losses to grow, with revenue holding steady.
AGMB Earnings Per Share
AGMB Quarterly Revenue
AGMB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$14.6M | -$416.6K |
AGMB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +15% | +6.3M shares |
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q4 2024 | — |
AGMB Net Leverage
AGMB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AGMB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.5 | Neutral |
| Stochastic | 7.4 | Oversold |
AGMB's weekly RSI is 36 (neutral) and its Stochastic is 7 (oversold).
AGMB PE vs Healthcare Sector
AGMB has no meaningful PE right now: it lost money over the past year.
AGMB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.37 | 24% below |
| 20 week MA | $11.3 | 44% below |
AGMB is in a downtrend: it's below all two of its weekly moving averages, and 44% below its 20-week average.
AGMB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $14.7 | $6.36 | -57% |
It's down 57% so far in 2026.